Literature DB >> 11456400

Hypoxia delays the intracellular Ca2+ clearance by Na+-Ca2+ exchanger in human adult cardiac myocytes.

S I Park1, E J Park, N H Kim, W K Baek, Y T Lee, C J Lee, C K Suh.   

Abstract

Transient myocardial ischemia during cardiac surgery causes a loss of energy sources, contractile depression, and accumulation of metabolites and H+ ion resulting in intracellular acidosis. The reperfusion following ischemic cardioplegia recovers intracellular pH, activates Na+-H+ exchange and Na+-Ca2+ exchange transports and consequently produces Ca2+ overload, which yields cell death. Among the various Ca2+ entry pathways, the Na+-Ca2+ exchanger is known to play one of the major roles during the ischemia/reperfusion of cardioplegia. Consequently, information on the changes in intracellular Ca2+ activities of human cardiac myocytes via the Na+-Ca2+ exchanger is imperative despite previous measurements of Ca2+ current of human single myocytes. In this study, human single myocytes were isolated from the cardiac tissues obtained during open-heart surgery and intracellular Ca2+ activity was measured with cellular imaging techniques employing fluorescent dyes. We report that the Na+-Ca2+ exchanger of adult cardiac myocytes is more susceptible to hypoxic insult than that of young patients.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11456400     DOI: 10.3349/ymj.2001.42.3.333

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  2 in total

1.  Regulation of blood-brain barrier permeability by transient receptor potential type C and type v calcium-permeable channels.

Authors:  Rachel C Brown; Ling Wu; Kali Hicks; Roger G O'neil
Journal:  Microcirculation       Date:  2008-05       Impact factor: 2.628

2.  Distinct Cellular Calcium Metabolism in Radiation-sensitive RKO Human Colorectal Cancer Cells.

Authors:  Yun Tai Kim; Soo Shin Jo; Young Jun Park; Myung Za Lee; Chang Kook Suh
Journal:  Korean J Physiol Pharmacol       Date:  2014-12-30       Impact factor: 2.016

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.